Filing metadata

Accession number
0001209191-22-019686
Form type
Form 4
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Mar 17, 2022
Reporting period
Mar 15, 2022
Description
Insider transaction

Explore SEC Filings Hub